Beta-hydroxy-betamethylbutyrate (HMB) and Sarcopenia

Risultato della ricerca: Contributo in libroChapter

Abstract

Beta‐hydroxy‐beta‐methylbutyrate (HMB) is an active metabolite of leucine, a branched‐chain essential amino acid entirely derived from food sources, and it has been studied for many decades (Figure 24.1). HMB per se is present in very small amounts of some foods, such as cauliflower, citrus fruit, avocado, and catfish. HMB is synthesized from leucine in two separate steps occurring in liver and muscle cell [1]. At muscle cells level, leucine has an explicit role in controlling and at the same time regulating protein synthesis, and HMB has an important role as a key active metabolite in this process. Nevertheless, only approximately 5% of leucine that we can eat with the usual diet is converted to HMB, which, in a subject weighing 70–80 kg, ends in the production of 0.2–0.4 g of HMB per day [2].
Lingua originaleEnglish
Titolo della pubblicazione ospiteSarcopenia
EditorJohn E. Morley Alfonso J. Cruz-Jentoft
Pagine355-366
Numero di pagine12
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • Leucine
  • Nutrition
  • Skeletal muscle
  • Geriatrics

Fingerprint

Entra nei temi di ricerca di 'Beta-hydroxy-betamethylbutyrate (HMB) and Sarcopenia'. Insieme formano una fingerprint unica.

Cita questo